Khulna University of Engineering & Technology
Central Library

Analogue-based drug discovery III / (Record no. 12409)

000 -LEADER
fixed length control field 05742cam a2200841Ii 4500
001 - CONTROL NUMBER
control field ocn826637765
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20171224114146.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu|||unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130204t20132013gw ac ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency DG1
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency DG1
Modifying agency EBLCP
-- N$T
-- MHW
-- YDXCP
-- COO
-- IDEBK
-- E7B
-- NOC
-- OCLCF
-- IUL
-- SCB
-- OCLCQ
-- CDX
-- NKT
-- OCLCQ
019 ## -
-- 828869678
-- 828896125
-- 961601655
-- 962705463
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783527651085
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 352765108X
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783527651115
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 352765111X
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781299241206
Qualifying information (MyiLibrary)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1299241204
Qualifying information (MyiLibrary)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9783527330737
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 3527330739
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000050562533
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000053030546
029 1# - (OCLC)
OCLC library identifier DKDLA
System control number 820120-katalog:000655918
029 1# - (OCLC)
OCLC library identifier NLGGC
System control number 382514440
029 1# - (OCLC)
OCLC library identifier NZ1
System control number 15340091
029 1# - (OCLC)
OCLC library identifier DEBBG
System control number BV043395341
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)826637765
Canceled/invalid control number (OCoLC)828869678
-- (OCoLC)828896125
-- (OCoLC)961601655
-- (OCoLC)962705463
037 ## - SOURCE OF ACQUISITION
Stock number 455370
Source of stock number/acquisition MIL
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM301.25
Item number .A53 2013
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 023000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 058170
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 072000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Source eflch
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1/9
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Analogue-based drug discovery III /
Statement of responsibility, etc edited by János Fischer, C. Robin Ganellin, David P. Rotella.
246 3# - VARYING FORM OF TITLE
Title proper/short title Analogue-based drug discovery 3
246 3# - VARYING FORM OF TITLE
Title proper/short title Analog-based drug discovery III
264 #1 -
-- Weinheim :
-- Wiley-VCH,
-- [2013]
264 #4 -
-- ©2013
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xviii, 385 pages) :
Other physical details illustrations, portraits
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
588 0# -
-- Online resource; title page from PDF title page (viewed June 30, 2014).
505 00 - FORMATTED CONTENTS NOTE
Title General Aspects. Pioneer and Analogue Drugs /
Statement of responsibility Janos Fischer, C Robin Ganellin, David P Rotella --
Title Competition in the Pharmaceutical Drug Development /
Statement of responsibility Christian Tyrchan, Fabrizio Giordanetto --
Title Metabolic Stability and Analogue-Based Drug Discovery /
Statement of responsibility Amit S Kalgutkar, Antonia F Stepan --
Title Use of Macrocycles in Drug Design Exemplified with Ulimorelin, a Potential Ghrelin Agonist for Gastrointestinal Motility Disorders /
Statement of responsibility Mark L Peterson, Hamid Hoveyda, Graeme Fraser, Eric Marsault, Rene Gagnon --
Title Drug Classes. The Discovery of Anticancer Drugs Targeting Epigenetic Enzymes /
Statement of responsibility A Ganesan --
Title Thienopyridyl and Direct-Acting P2Y Receptor Antagonist Antiplatelet Drugs /
Statement of responsibility Joseph A Jakubowski, Atsuhiro Sugidachi --
Title Selective Estrogen Receptor Modulators /
Statement of responsibility Amarjit Luniwal, Rachael Jetson, Paul Erhardt --
Title Discovery of Nonpeptide Vasopressin V2 Receptor Antagonists /
Statement of responsibility Kazumi Kondo, Hidenori Ogawa --
Title The Development of Cysteinyl Leukotriene Receptor Antagonists /
Statement of responsibility Peter R Bernstein --
Title Case Studies. The Discovery of Dabigatran Etexilate /
Statement of responsibility Norbert Hauel, Andreas Clemens, Herbert Nar, Henning Priepke, Joanne van Ryn, Wolfgang Wienen --
Title The Discovery of Citalopram and Its Refinement to Escitalopram /
Statement of responsibility Klaus P Bogeso, Connie Sanchez --
Title Tapentadol : From Morphine and Tramadol to the Discovery of Tapentadol /
Statement of responsibility Helmut Buschmann --
Title Novel Taxanes: Cabazitaxel Case Study /
Statement of responsibility Herve Bouchard, Dorothee Semiond, Marie-Laure Risse, Patricia Vrignaud --
Title Discovery of Boceprevir and Narlaprevir: A Case Study for Role of Structure-Based Drug Design /
Statement of responsibility Srikanth Venkatraman, Andrew Prongay, George F Njoroge --
Title A New-Generation Uric Acid Production Inhibitor: Febuxostat /
Statement of responsibility Ken Okamoto, Shiro Kondo, Takeshi Nishino.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
520 ## - SUMMARY, ETC.
Summary, etc "Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and--together with the previous volumes--constitutes the first systematic approach to drug analogue development"--Publisher's website.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug development.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Drug Guides.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Nursing
-- Pharmacology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacy.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug development.
Source of heading or term fast
-- (OCoLC)fst00898670
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
Source of term local
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fischer, János,
Relator term editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ganellin, C. R.
Fuller form of name (C. Robin),
Relator term editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rotella, David P.,
Relator term editor.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
Title Analogue-based drug discovery III.
Place, publisher, and date of publication Weinheim : Wiley-VCH, [2013]
International Standard Book Number 9783527330737
Record control number (OCoLC)825555931
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://onlinelibrary.wiley.com/book/10.1002/9783527651085
Public note Wiley Online Library
938 ## -
-- Coutts Information Services
-- COUT
-- 24876696
-- 130.00 GBP
938 ## -
-- EBL - Ebook Library
-- EBLB
-- EBL1123660
938 ## -
-- ebrary
-- EBRY
-- ebr10662582
938 ## -
-- EBSCOhost
-- EBSC
-- 542882
938 ## -
-- Ingram Digital eBook Collection
-- IDEB
-- cis24876696
938 ## -
-- YBP Library Services
-- YANK
-- 9985301
938 ## -
-- YBP Library Services
-- YANK
-- 10226219
938 ## -
-- YBP Library Services
-- YANK
-- 10247713
994 ## -
-- 92
-- DG1

No items available.



Khulna University of Engineering & Technology
Funded by: HEQEP, UGC, Bangladesh